473927-72-9 Usage
Uses
Used in Pharmaceutical Industry:
(1H-imidazol-2-ylmethyl)methylamine(SALTDATA: 2HCl) is used as a building block for drug development due to its unique imidazole ring structure, which can be incorporated into the synthesis of various pharmaceuticals.
Used in Vasodilator Applications:
In the medical field, (1H-imidazol-2-ylmethyl)methylamine(SALTDATA: 2HCl) is used as a vasodilator for its potential to help in the relaxation of blood vessels, thereby improving blood flow.
Used in Pharmaceutical Formulation Stabilization:
(1H-imidazol-2-ylmethyl)methylamine(SALTDATA: 2HCl) is used as a stabilizer in certain pharmaceutical formulations to maintain the integrity and effectiveness of the final product over time.
Check Digit Verification of cas no
The CAS Registry Mumber 473927-72-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,3,9,2 and 7 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 473927-72:
(8*4)+(7*7)+(6*3)+(5*9)+(4*2)+(3*7)+(2*7)+(1*2)=189
189 % 10 = 9
So 473927-72-9 is a valid CAS Registry Number.
473927-72-9Relevant articles and documents
Structure and property based design of factor Xa inhibitors: Biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs
Young, Robert J.,Borthwick, Alan D.,Brown, David,Burns-Kurtis, Cynthia L.,Campbell, Matthew,Chan, Chuen,Charbaut, Marie,Convery, Maire A.,Diallo, Hawa,Hortense, Eric,Irving, Wendy R.,Kelly, Henry A.,King, N. Paul,Kleanthous, Savvas,Mason, Andrew M.,Pateman, Anthony J.,Patikis, Angela N.,Pinto, Ivan L.,Pollard, Derek R.,Senger, Stefan,Shah, Gita P.,Toomey, John R.,Watson, Nigel S.,Weston, Helen E.,Zhou, Ping
, p. 28 - 33 (2008/09/17)
Structure and property based drug design was exploited in the synthesis of sulfonamidopyrrolidin-2-one-based factor Xa (fXa) inhibitors, incorporating basic biaryl P4 groups, producing highly potent inhibitors with significant anticoagulant activities and encouraging oral pharmacokinetic profiles.
Substituted amino methyl factor Xa inhibitors
-
, (2008/06/13)
The present application describes substituted-aminomethyl substituted compounds and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.
